CHM 0.00% 1.4¢ chimeric therapeutics limited

valuation thoughts, page-121

  1. 890 Posts.
    lightbulb Created with Sketch. 469
    1. Top tier team working in a hot area
    2. Compelling assets that are clinical, not pre clinical
    3. Large TAM with small market cap
    4. So far so good on safety front and encouraging phase 1 results given the context

    I'll take my chances for now.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.